Integrins team up with tyrosine kinase receptors and plexins to control angiogenesis

Current Opinion in Hematology

Volumn 15, Issue 3, 2008, Pages 235-242

  Serini, Guido ^a   Napione, Lucia ^a   Bussolino, Federico ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Sp 142 ^*  (Italy)

Author keywords

Angiopoietins; Autocrine loops; Endothelium; Semaphorins; VEGF

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; COLLAGEN TYPE 1; FIBRONECTIN; INTEGRIN; NEUROPILIN; PLEXIN; PROTEIN SUBUNIT; SCLEROPROTEIN; SEMAPHORIN; TYROSINE KINASE RECEPTOR; VASCULOTROPIN RECEPTOR 2; VERY LATE ACTIVATION ANTIGEN 1; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 5; VITRONECTIN RECEPTOR;

ANGIOGENESIS; CARDIOVASCULAR SYSTEM; CELL ADHESION; CELL MIGRATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; MOLECULAR INTERACTION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; INTEGRINS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE;

EID: 41949130937     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3282fa745b     Document Type: Review

References (62)

1. Hynes RO. Cell-matrix adhesion in vascular development. J Thromb Haemost 2007; 5 (Suppl 1):32-40.
2. Serini G, Valdembri D, Bussolino F. Integrins and angiogenesis: a sticky business. Exp Cell Res 2006; 312:651-658.
3. Borges E, Jan Y, Ruoslahti E. PDGF-receptor- and VEGF-receptor-2 bind to the 3 integrin through its extracellular domain. J Biol Chem 2000; 275:39867-39873.
4. Soldi R, Mitola S, Strasly S, et al. Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 1999; 18:734-740.
5. Mahabeleshwar GH, Feng W, Phillips DR, et al. Integrin signaling is critical for pathological angiogenesis. J Exp Med 2006; 203:2495-2507.
6. Mahabeleshwar GH, Feng W, Reddy K, et al.Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res 2007; 101:570-580.
7. Tian F, Zhu CH, Zhang XW, et al. Philinopside E, a new sulfated saponin from sea cucumber, blocks the interaction between kinase insert domain-containing receptor (KDR) and alphavbeta3 integrin via binding to the extracellular domain of KDR. Mol Pharmacol 2007; 72:545-552.
8. Dardik R, Inbal A. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF. Exp Cell Res 2006; 312:2973-2982.
9. Weis S, Lindquist JN, Barnes LA, et al. Cooperation between VEGF and β3 integrin during cardiac vascular development. Blood 2007; 109:962-1970.
10. Reynolds AR, Reynolds LE, Nagel TE, et al. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res 2004; 64:8643-8650.
11. Silvestre JS, Thery C, Hamard G, et al. Lactadherin promotes VEGF-dependent neovascularization. Nat Med 2005; 11:499-506.
12. Mitola S, Brenchio B, Piccinini M, et al. Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. Circ Res 2006; 98:45-54.
13. Jekely G, Sung HH, Luque CM, et al. Regulators of endocytosis maintain localized receptor tyrosine kinase signaling in guided migration. Dev Cell 2005; 9:197-207.
14. Seo DW, Li H, Guedez L, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell 2003; 114:171-180.
15. Olsson AK, Dimberg A, Kreuger J, et al. VEGF receptor signalling: in control of vascular function. Nat Rev Mol Cell Biol 2006; 7:359-371.
16. Arais-Salgado AR, Haj F, Dubois C, et al. PTB-1B is essential positive regulator of platelet integrin signals. J Cell Biol 2005; 170:837-845.
17. Zhang X, Groopman JE, Wang JF. Extracellular matrix regulates endothelial functions through interaction of VEGFR-3 and integrin α5β1. J Cell Physiol 2005; 202:205-214.
18. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407:242-248.
19. Cascone I, Napione L, Maniero F, et al. Stable interaction between alpha5-beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol 2005; 170:993-1004.
20. Vlahakis NE, Young BA, Atakilit A, et al. Integrin alpha9beta1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 2007; 282:15187-15196. This study shows that VEGF-A-induced adhesion and migration of endothelial cells are dependent on the integrin α9β1 and that VEGF-A is a direct ligand for this integrin. Adhesion and migration of these cells on the 165 and 121 isoforms of VEGF-A depend on cooperative input from α9β1 and VEGF-R2. The binding of the integrin with selected VEGF-A isofroms may contribute to the different biological activities of VEGF-A isoforms.
21. Vlahakis N, Young BA, Atakilit A, et al. The lymphangiogenic vascular enothelial growth factors VEGF-C and -D are ligands for the integrin alpha9-beta1. J Biol Chem 2005; 280:4544-4554.
22. Hutchings H, Ortega N, Plouët J. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J 2003; 17:1520-1522.
23. Ruhrberg C, Gerhardt H, Golding M, et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002; 16:2684-2698.
24. Stalmans I, Ng YS, Rohan R, et al. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 2002; 109:327-336.
25. Dallabrida SM, Ismail N, Oberle JR, et al. Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 2005; 96:e8-e24.
26. Hu B, Jarzynka MJ, Guo P, et al. Angiopoietin 2 induces glioma cell invasion by stimulating matrix metalloprotease 2 expression through the alphavbeta1 integrin and focal adhesion kinase signaling pathway. Cancer Res 2006; 66:775-783.
27. Carlson T, Feng Y, Maisonpierre P, et al. Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 2001; 278:26516-26525.
28. Imanishi Y, Hu B, Jarzynka MJ, et al. Angiopoietin-2 stimulates breast cancer metastasis through the alpha(5)beta(1) integrin-mediated pathway. Cancer Res 2007; 67:4254-4263.
29. Kruger RP, Aurandt J, Guan KL. Semaphorins command cells to move. Nat Rev Mol Cell Biol 2005; 6:789-800.
30. Bussolino F, Valdembri D, Caccavari F, et al. Semaphoring vascular morphogenesis. Endothelium 2006; 13:81-91.
31. Serini G, Valdembri D, Zanivan S, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424:391-397.
32. Toyofuku T, Yabuki M, Kamei J, et al. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1. EMBO J 2007; 26:1373-1384. This study reports for the first time a Sema that exerts its effect exclusively in adult angiogenesis, whereas embryo vascular development is unaffected. Indeed, this concept parallels the observation seen in some null mice of VEGF family (i.e., placental growth factor) in which the vascular phenotype appears in stressed conditions of adult life.
33. Kawasaki T, Kitsukawa T, Bekku Y, et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999; 126:4895-4902.
34. Yuan L, Moyon D, Pardanaud L, et al. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 2002; 129:4797-4906.
35. Shoji W, Isogai S, Sato-Maeda M, et al. Semaphorin3a1 regulates angioblast migration and vascular development in zebrafish embryos. Development 2003; 130:3227-3236.
36. Torres-Vazquez J, Gitler AD, Fraser SD, et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell 2004; 7:117-123.
37. Bates D, Taylor GI, Minichiello J, et al. Neurovascular congruence results from a shared patterning mechanism that utilizes semaphorin3A and neuropilin-1. Dev Biol 2003; 255:77-98.
38. Gu C, Yoshida Y, Livet J, et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 2005; 307:265-268.
39. Vieira JM, Schwarz Q, Ruhrberg C. Selective requirements for NRP1 ligands during neurovascular patterning. Development 2007; 134:1833-1843.
40. Chia R, Achilli F, Festing MF, et al. The origins and uses of mouse outbred stocks. Nat Genet 2005; 37:1181-1186.
41. Damon DH. Vascular endothelial-derived semaphorin 3 inhibits sympathetic axon growth. Am J Physiol Heart Circ Physiol 2006; 290:H1220-H1225.
42. Serini G, Ambrosi D, Giraudo E, et al. Modeling the early stages of vascular network assembly. EMBO J 2003; 22:1771-1779.
43. Vacca A, Scavelli C, Serini G, et al. Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 2006; 108:1661-1667.
44. Lee S, Chen TT, Barber CL, et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell 2007; 130:691-703.
45. Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, et al. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 2007; 282:26294-26305.
46. Kessler O, Shraga-Heled N, Lange T, et al. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res 2004; 64:1008-1015.
47. Potiron VA, Sharma G, Nasarre P, et al. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Res 2007; 67:8708-8715.
48. Bielenberg DR, Hida Y, Shimizu A, et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest 2004; 114:1260-1271.
49. Kashiwagi H, Shiraga M, Kato H, et al. Negative regulation of platelet function by a secreted cell repulsive protein, semaphorin 3A. Blood 2005; 106:913-921.
50. Lepelletier Y, Smaniotto S, Hadj-Slimane R, et al. Control of human thymocyte migration by neuropilin-1/semaphorin-3A-mediated interactions. Proc Natl Acad Sci U S A 2007; 104:5545-5550.
51. Toyofuku T, Yoshida J, Sugimoto T, et al. FARP2 triggers signals for Sema3A-mediated axonal repulsion. Nat Neurosci 2005; 8:1712-1719.
52. Banu N, Teichman J, Dunlap-Brown M, et al. Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J 2006; 20:2150-2152.
53. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-687.
54. Campbell ID, Ginsberg MH. The talin-tail interaction places integrin activation on FERM ground. Trends Biochem Sci 2004; 29:429-435.
55. Calderwood DA. Integrin activation. J Cell Sci 2004; 117:657-666.
56. Kinbara K, Goldfinger LE, Hansen M, et al. Ras GTPases: integrins' friends or foes? Nat Rev Mol Cell Biol 2003; 4:767-776.
57. Acevedo LM, Barillas S, Weis SM, et al. Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor. Blood 2008; 7 Jan [Epub ahead of print].
58. Oinuma I, Katoh H, Negishi M. Semaphorin 4D/Plexin-B1-mediated R-Ras GAP activity inhibits cell migration by regulating beta(1) integrin activity. J Cell Biol 2006; 173:601-613.
59. Basile JR, Barac A, Zhu T, et al. Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B. Cancer Res 2004; 64:5212-5224.
60. Conrotto P, Valdembri D, Corso S, et al. Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood 2005; 105:4321-4329.
61. Basile JR, Gavard J, Gutkind JS. Plexin-B1 utilizes RhoA and Rho kinase to promote the integrin-dependent activation of Akt and ERK and endothelial cell motility. J Biol Chem 2007; 282:34888-34895.
62. Swiercz JM, Worzfeld T, Offermanns S. ERBB-2 and met reciprocally regulate cellular signaling via plexin-B1. J Biol Chem 2007 [Epub ahead of print].